Legal & Regulatory Intelligence
for Emerging Technologies
A coordinated network of attorneys and specialist advisors operating at the intersection of biotechnology, digital assets, and artificial intelligence.
Quiet authority. Coordinated counsel.
We are a private consortium that pairs licensed counsel with subject-matter advisors across biotechnology, digital assets, and artificial intelligence. Engagement is offered on a discretionary basis following internal review.
The firms and attorneys in our network are retained directly under their own engagement agreements. Our role is coordination, intelligence, and structuring — the matters they take, they take in their own name.
Specialised across emerging-technology law.
Five core domains where regulatory exposure compounds quickly. Each is staffed by counsel and advisors retained for that practice alone.
Biotechnology & Life Sciences
FDA-adjacent regulatory structuring, RUO research compliance frameworks, intellectual-property licensing, and laboratory advisory.
Digital Assets & Blockchain
Token structuring, exchange risk frameworks, smart-contract coordination, and market-operations advisory.
Artificial Intelligence & Data Systems
AI governance, data-usage compliance, model-deployment risk, and API/data licensing.
Corporate Structuring
US and offshore entity formation, banking navigation, tax-structuring coordination, and M&A advisory.
Regulatory & Compliance Intelligence
Risk mapping, documentation systems, and internal compliance frameworks for high-exposure operators.
Three formats. Accepted by review.
Ongoing strategic support for operators with continuous regulatory exposure. Billed on a flat-rate retainer with a defined consultation cadence.
Project-based advisory with a defined scope, milestone schedule, and termination criteria. Suitable for transactions, structuring, and discrete reviews.
High-risk structuring and defence strategy. Confidential, reviewed at intake, accepted only after a conflict and risk assessment.
Submit your matter for internal review.
All correspondence is treated as confidential and routed only to the relevant practice group.
Begin Intake